Dopamine transporter genotype as a risk factor for obesity in African-American smokers

被引:38
作者
Epstein, LH
Jaroni, JL
Paluch, RA
Leddy, JJ
Vahue, HE
Hawk, L
Wileyto, EP
Shields, PG
Lerman, C
机构
[1] SUNY Buffalo, Sch Med, Dept Pediat, Buffalo, NY 14214 USA
[2] SUNY Buffalo, Sch Med, Sports Med Inst, Buffalo, NY 14214 USA
[3] SUNY Buffalo, Dept Psychol, Buffalo, NY 14214 USA
[4] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[5] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[6] Georgetown Univ, Dept Oncol, Lombardi Canc Ctr, Washington, DC USA
来源
OBESITY RESEARCH | 2002年 / 10卷 / 12期
关键词
smoking; dopamine transport; African American;
D O I
10.1038/oby.2002.168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the association between a polymorphism related to dopamine function, dopamine transport (SLC6A3), and obesity in smokers. Research Methods and Procedures: Logistic regression was used to assess the relationship between this genetic polymorphism and obesity (body mass index greater than or equal to30 kg/m(2)) from a sample of 510 smokers who smoked at least 10 cigarettes per day and who were participating in a study designed to examine genetic and nongenetic predictors of response to a pharmacological treatment. Results: The likelihood of obesity in African Americans (N = 90) with the 10/10 SLC6A3 genotype was 5.16 times that of African Americans with 9/9 or 9/10 SLC6A3 genotypes (odds ratio = 5.16, confidence interval = 1.60 to 16.65). There was no association of the SLC6A3 genotype with obesity for non-Hispanic whites (N = 420). Discussion: These results suggest that variants of the dopamine transporter gene may be related to obesity in African-American smokers. Possible mechanisms responsible for the association between dopamine transport and obesity in African-American smokers are discussed.
引用
收藏
页码:1232 / 1240
页数:9
相关论文
共 69 条
[1]  
ALLISON DB, 1994, INT J OBESITY, V18, P363
[2]  
Bannon Michael J., 1995, P179
[3]   Body weight gain induced by antipsychotic drugs: mechanisms and management [J].
Baptista, T .
ACTA PSYCHIATRICA SCANDINAVICA, 1999, 100 (01) :3-16
[4]   Food reward: Brain substrates of wanting and liking [J].
Berridge, KC .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1996, 20 (01) :1-25
[5]  
Bild D E, 1993, Ann Epidemiol, V3, P636
[6]   Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice [J].
Bina, KG ;
Cincotta, AH .
NEUROENDOCRINOLOGY, 2000, 71 (01) :68-78
[7]  
Chitwood LF, 1996, INT J OBESITY, V20, P455
[8]   Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice. [J].
Cincotta, AH ;
Tozzo, E ;
Scislowski, PWD .
LIFE SCIENCES, 1997, 61 (10) :951-956
[9]   Economic costs of obesity and inactivity [J].
Colditz, GA .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1999, 31 (11) :S663-S667
[10]   The search for human obesity genes [J].
Comuzzie, AG ;
Allison, DB .
SCIENCE, 1998, 280 (5368) :1374-1377